Table 2 Characteristics of “gilz-positive” patients
Overall patients n = 31 | ARDS | Steroidsa | Vasoactive agentsa | Pneumonia at inclusion | Septic shock at inclusion | Vital status on day 28 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
No n = 14 | Yes n = 17 | No n = 24 | Yes n = 7 | No n = 10 | Yes n = 21 | No n = 13 | Yes n = 18 | No n = 12 | Yes n = 19 | Dead n = 12 | Alive n = 19 | |
gilz-positive patients | 2/14 (14%) | 9/17 (53%) | 6/24 (25%) | 5/7 (71%) | 3/10 (30%) | 8/21 (38%) | 3/13 (23%) | 8/18 (44%) | 3/12 (25%) | 8/19 (42%) | 4/12 (33%) | 7/19 (37%) |
p value | 0.025 | 0.024 | 0.660 | 0.220 | 0.332 | 0.842 | ||||||